Supplementary Experimental Procedures
Abbreviations CNS, central nervous system; EAE, experimental autoimmune encephalomyelitis; EMSA, electrophoretic mobility shift assay; FOXP3, forkhead box p3; i.p., intraperitoneal; IFN-, interferon-; IL, interleukin; LN, draining lymph nodes; MOG, myelin oligodendrocyte glycoprotein; MS, multiple sclerosis; PBS, phosphate buffered saline; Prkca -/-, PKC-deficient; PMA, phorbol 12-myristate13-acetate; s.c., subcutaneous; SC, spinal cord; STAT, Signal transducer and activator of transcription; TGF, transforming growth factor ; TGFR, transforming growth factor  receptor; Th cell, T helper cell; TNF-, tumor necrosis factor-.
Antibodies and Reagents
For the stimulations with TGF (5ng/ml), the cells were maintained in serum-free X-vivo 20 medium (Lonza). The specific PKC- low molecular weight inhibitor Gö6976 (PKC LMWI; 1µM) (MartinyBaron et al., 1993) and TGFRI kinase inhibitor (TGFRI LMWI; 1µM) were obtained from Calbiochem. [-32 P]Adenosine 5'-triphosphate (ATP) was purchased from Amersham. Protein lysates were subjected to immunoblotting with antibodies from Cell Signaling against phospho-SMAD2, phospho-SMAD3 (C25A9), SMAD2 (L16D3), and SMAD3 (C67H9), phospho-STAT3, STAT3, phospho-p38, p38, phospho-JNK, JNK, phospho ERK1-2, ERK1-2; from Santa Cruz for TGFRI (H-100), from Millipore for PKC (M-4). The antibodies against murine CD4, CD25, IFN-, AnnexinV, 7AAD and IL-17A were obtained from BD Pharmingen. CD11c, MHCII, CD40, CD86, V2-TCR, CCR6, ROR-t, T-bet and FOXP3 were obtained from eBioscience. TGFRII-PE was obtained from R&D Systems. Neutralizing anti-IFN-, anti-IL-4 and anti-IL-12 were obtained from BD Pharmingen. The antibodies used for T cell stimulation were monoclonal antibodies (mAbs) against CD28 (clone 28.2) and 2C11 (mouse). The cytokines were obtained from eBiosciences. The polyclonal phosphospecific (p)Thr 200 TGFRI antibody was raised and affinity-purified against the phosphothreoninecontaining peptide sequence NH 2 -LLVQR-T(p)-IARTI -COOH was coupled to KLH.
Antigen Recall Assay
On day 10, splenocyte suspensions were generated from MOG peptide immunized Prkca -/-or Prkca +/+ mice along with PBS-treated control mice. Splenocytes from individual mice, depleted of red blood cells with lysing buffer (R&D), were plated in duplicates (5x10 5 cells/well) in 200µl IMDM +++ medium containing 0, 1, 10, or 100µg/ml MOG peptide and cultured at 37°C in 5% CO 2 . After 72 hours, cytokine production after MOG 35-55 peptide restimulation was measured in the cell culture supernatants. Cytokine amounts were analyzed with BioPlex multianalyte technology (BioRad).
Chromatin Immunoprecipitation (ChIP) Assay
The chromatin immunoprecipitation (ChIP) assay was performed with a ChIP assay kit according to the recommendations of the manufacturer (Imgenex) in combination with the Cold Spring Harbor protocol (Carey et al., 2009) . Briefly, Prkca +/+ and Prkca -/-naïve T cells were isolated using the CD4 + T cell isolation kit II (Miltenyi Biotech). The polarization of CD4 + T cells was performed using solid-phase anti-CD3 (5µg/ml) and soluble anti-CD28 (1µg/ml) in X-vivo medium supplemented with TGF (5ng/ml) and IL-6 (20ng/ml). The cells were harvested after 16 hours, fixed in 1% formaldehyde at 37°C for 10 min, and the cross-linking was quenched by the addition of 1.375 M glycine. The cells were then washed twice with ice-cold PBS and lysed in cold cell lysis buffer for ChIP (5mM PIPES (pH 8.0), 85mM KCl, 0.5% Nonidet P-40 (NP-40)) for 10 min. The cell pellets were lysed following centrifugation in 1 ml nuclei lysis buffer for ChIP (50mM Tris-Cl (pH 8.0), 10mM EDTA, 1% SDS) supplemented with protease inhibitors and were incubated for 10 min on ice. Following sonication with 25-30s pulses using a Bioruptor Next Generation (Diagenode), the samples were centrifuged for 10 min at 12.000 rpm. The sheared chromatin was used to set up immunoprecipitation reactions with 5µg of the indicated Abs (IgG sc-2027 Santa Cruz; STAT3 483 Santa Cruz) at 4°C overnight. Magna ChIP protein G magnetic beads were added for 2 hours, and the samples were sequentially washed once with the buffers provided by the supplier (IMGENEX; high to low salt). The DNA-protein complex was eluted by heating at 65°C overnight, and the DNA was eluted using the IPure kit (Diagenode). Realtime PCR was performed with the following primers and probes using an ABI PRIM 7000 Sequence Detection System (Applied Biosystems): Il17a minimal promoter (-243 to -176) 5' GAACTTCTGCCCTTCCCATCT 3' and 5' CAGCACAGAACCACCCCTTT3' with the following probe 5´ FAM-CCTTCGAGACAGATGTTGCCCGTCA-TAMRA-3` (Schraml et al., 2009) . Unspecific IgG Ab was used as negative control.
Confocal Immunofluorescence
Confocal immunofluorescence staining has been previously described (Nurieva et al., 2009) . Briefly, human naïve CD4 + cells were isolated using the human CD4 + CD62L + T cell isolation kit II (Miltenyi Biotech). The cells were fixed, permeabilized and stained with primary antibodies (anti-PKC, anti-TGFRI and anti-gp130). Colocalization was measured on single confocal sections using the colocalization module of Imaris 5.0.1, 64-bit version (Bitplane AG). At least 30 individual cells were analyzed for each condition. Colocalization was estimated and expressed with the Mander's coefficient (range from -1.0 to 1.0, with 1.0 indicating complete colocalization).
Experimental Autoimmune Encephalomyelitis Assay (EAE)
Mice were injected s.c. in the hind flank (100µl) with 200µg MOG 35-55 peptide (PolyPeptide group) in complete Freund's adjuvant (CFA) containing 5mg/ml H37RA (Mycobacterium tuberculosis, Difco Laboratories). In addition, pertussis toxin (Sigma; 200ng/mouse) was administered i.p. on the day of immunization and 48 hours later. Signs of EAE were assigned scores on a scale of 0-4 as follows: 0=none, 0.5=distal weak or spastic tail, 1=complete limp tail, 1.5=limp tail and hind limp weakness (feet slip through cage grill), 2=unilateral partial hind limb paralysis, 2.5=bilateral partial hind limb paralysis, 3=complete bilateral hind limb paralysis, 3.5=complete hind limb and unilateral partial forelimb paralysis, 4=death or total paralysis (Kaminski et al., 2011) . The mean EAE disease scores were calculated by comparing the mean values of the WT and Prkca -/-mice at the onset (day 6-13) and at disease progression (day 14-20) using an unpaired Student's t-test.
Flow Cytometry
For intracellular cytokine staining, cells were restimulated with phorbol 12-myristate 13-acetate (PMA) (Sigma; 10ng/ml) and ionomycin (Sigma; 125ng/ml) for 4 hours in the presence of Golgi stop (BD Bioscience; 0.65µl/ml). The cell surfaces were stained before the cells were fixed and permeabilized with BD Cytofix-Cytoperm and stained for cytokines. Intracellular staining for FOXP3, ROR-t or T-BET was done without stimulation, with the eBioscience FOXP3 fixation-permeabilization kit. The affinity-purified (p)Thr 200 TGFRI antibody (Polypeptide group) was labeled using an Alexa Fluor 488 goat-anti-rabbit IgG1 antibody (Molecular Probes).
Preparation of CNS Mononuclear Cells
Mononuclear infiltrating cells were isolated from the CNS (central nervous system) and SC (spinal cord) as described by Korn et al. (Korn et al., 2007) . Briefly, mice were perfused through the left cardiac ventricle. Brains and spinal cords were excised and dissociated for 45 min at 37°C by digestion with collagenase D (2.5mg/ml; Roche) and DNaseI (1mg/ml; Sigma) in PBS (containing 2% FCS). Dispersed cells were passed through a 70µm nylon mesh, pelleted by centrifugation, resuspended, layered onto a Percoll density gradient (GE Healthcare) and centrifuged for 20 min at 1200rpm and room temperature without break. CNS mononuclear cells were isolated by collection of the interphase fraction between 30% and 70% Percoll. After intensive washing in PBS, cells were restimulated in vitro with PMA-ionomycin (10ng/ml/125ng/ml) for 4 hours in the presence of Golgi stop (0.65µl/ml; BD Bioscience) and analyzed by flow cytometry.
Protein Kinase Assay
The protein kinase assay has been previously described (Zhou and Littman, 2009) . Briefly, the PKC-and TGFRII-dependent phosphorylation of the TGFRI proteins was measured by the incorporation of inorganic phosphate 32 P i from  32 P-ATP. A TGFRI LMWI (1µM) was used to prevent the autophosphorylation of TGFRI. Peptides of the T200WT (YDMTTSGSGSGLPLLVQRTIARTIV) and T200V mutant (YDMTTSGSGSGLPLL-VQRVIARTIV) motifs were generated. The incorporated radioactivity was measured using SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and X-ray autoradiography. For the peptide phosphorylation assays, the level of radioactivity bound to phosphocellulose filters was counted using the Wallac Micro 1450 (Perkin Elmer). The phosphosite prediction was done according to (Fujii et al., 2004) .
Reporter Gene Assay
For the reporter gene expression assay Jurkat-TAg cells were transfected with the indicated expression constructs (K368R, kinase-dead PKC mutant) and measured as previously described (Hermann-Kleiter et al., 2008; Yang et al., 2011) .
Transfection of HEK293T Cells
HEK293T cells (Thermo Scientific) were maintained in DMEM medium (Biochrom), supplemented with 10% FCS (Life Technologies) and 1% L-glutamine and antibiotics. Transfection of expression vectors was performed in Opti-MEM medium (Invitrogen) using Metafectene reagent (Biontex) according to the manufacturer's instructions. In brief, a total of 1x10 6 HEK293T cells were co-transfected (18-24 hours) with expression vectors (5µg) encoding HIS 6 -tagged PKC WT or mutant (A25E, constitutively active mutant; CF, catalytic fragment (Baier, 2003; Yang et al., 2011) ) with FLAG-tagged WT TGFRI as indicated. Using Ni 2+ -NTA Magnetic Agarose beads (Qiagen) PKC expression constructs were subsequently purified according to the manufacturer's instructions. In brief, transfected cells were lysed in lysis buffer (0.5% NP-40), incubated with 5% Ni 2+ -NTA beads and His 6 -tagged proteins bound to magnetic beads were collected in the eluate and resolved by SDS-PAGE.
Immunoblotting
Cells were lysed in ice-cold lysis buffer [5mM NaP 2 P, 5mM NaF, 5mM Na 3 VO 4 , 5mM EDTA, 150mM NaCl, 50mM tris (pH 7.3), 1% NP-40, aprotinin and leupeptin (50µg/ml each)] and centrifuged at 15000xg for 15 min at 4°C. Cell lysates were electrophoresed on a NuPAGE gel (Invitrogen) and transferred onto a polyvinylidene difluoride (PVDF) membrane (Millipore) by semidry blotting (90mA, 90 min). The primary antibodies were diluted in tris-buffered saline containing 0.5% Tween-20 and either with 5% nonfat dry milk or with 5% bovine serum albumin (BSA) for phospho antibodies. Peroxidase-conjungated antibodies (Pierce) served as secondary reagents (1:5000). Enhanced chemiluminescence was used for antigen detection (Super Signal, Pierce). As a loading control for whole cell lysates -Actin or FYN (Santa Cruz) was applied. As a loading control for nuclear fractions, DNA polymerase- (Santa Cruz) was applied. 
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AnnV -7AAD -(%) 21.9 ± 6.7 88.4 ± 2.6 19.0 ± 6.9 88.6 ± 3.5 A. Naive CD3 + T cells were stimulated in serum free X-vivo 20 with TGF (5ng/ml) as indicated. Cells were lysed and levels of (A) phospho-JNK (D) phospho-p38 and (F) phospho-ERK1-2 were determined by immunoblot. Levels of total proteins confirmed equal loading and respective quantification of densitometric analysis is shown in (B-C; E-G). (H) The phosphorylation level of AKT (T 308 ) between WT and Prkca -/-CD3 + T cells was determined by flow cytometry. (I) Naïve CD4 + CD62L hi T cells were cultured under indicated Th cell polarizing conditions for 3 days and mRNA expression of Eomesodermin (EOMES) was determined by quantitative RT-PCR. The data were normalized to GAPDH mRNA and are presented relative to the Th0 levels (n = 3). (A-H) The data are representative of at least two independent experiments. (B-C; E; H-I) Error bars, mean ± SEM.
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